ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

NCI-Approved Clinical Trials

January 26, 2007